UNSPSC 51393601: Doxaminol

This classification denotes a beta-adrenergic agonist with the molecular formula C26H29NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1RZ4ML637I, chemically known as 6,11-dihydro-n-(2-hydroxy-3-phenoxypropyl)-n-methyldibenz(b,e)oxepin-11-ethylamine but generally known as doxaminol, which bears US NIH Compound Identifier 68721. European Medicines Agency schedules Doxaminol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06381MIG. The term DOXAMINOL is an International Non-Proprietary Name.

UNSPSC 51393601 Doxaminol is a Commodity code that covers pharmaceutical products and related health-supply procurement by state and local government entities. Recent state and local solicitations under this code show activity in naloxone procurement and pharmacy benefit management systems rather than doxaminol specifically. Seminole County, Florida solicited 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding (IFB), with quarterly deliveries to the county community health building and all shipping costs included in vendor proposals. The Texas Health and Human Services Commission issued a Request for Information to explore direct-to-manufacturer prescription fulfillment models, seeking vendor capability data on negotiated net pricing and outcomes-based agreements for self-insured health plans and state agencies outside traditional pharmacy benefit manager and group purchasing organization channels. Issuing bodies using this code include state health departments and county public health systems focused on opioid response, emergency preparedness, and pharmacy benefit administration.

Seminole County, Florida represents the most recent concrete procurement activity under this code, with an IFB (IFB60459723LAS) posted June 30, 2026, and a response deadline of July 26, 2023 for naloxone and drug deactivation systems. The Texas HHS Commission's RFI (HHS0017013) posted April 3, 2026, signals state-level interest in restructuring pharmacy procurement relationships but remains an exploratory information-gathering phase without committed budget or timeline. Florida and Texas dominate recent activity. The Seminole County procurement requires vendors to comply with drug-free workplace certification, E-Verify employment verification, and potential FEMA compliance including Clean Air Act and Federal Water Pollution Control Act adherence; the contract includes a three-month probationary termination period and optional one-year renewal following an initial two-year term. No set-aside designations for disadvantaged enterprises are specified in either opportunity.